Insider Trading & Ownership of Steve Elms

Location
New York, NY
Summary
The estimated net worth of Steve Elms is at least $34,189,812 dollars as of 09 Mar 2026. Steve Elms is the Director of ADMA BIOLOGICS, INC. and owns shares of ADMA BIOLOGICS, INC. (ADMA) stock worth about $33.14M. Steve Elms is the Director of Marker Therapeutics, Inc. and owns shares of Marker Therapeutics, Inc. (MRKR) stock worth about $1.05M.
Signature
/s/ Steve Elms, by Michael A. Goldstein as Attorney-in-fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Steve Elms and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Quick Takeaways

  • Steve Elms has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $34,189,812.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: ADMA BIOLOGICS, INC. ($33,139,130).
  • Past-year value change for that position: -$8,611,913.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Steve Elms

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ADMA ADMA BIOLOGICS, INC. Director $33,139,130 -$8,611,913 -21% 05 Mar 2026
MRKR Marker Therapeutics, Inc. Director $1,050,682 17 Nov 2025
ELEV Elevation Oncology, Inc. Director 23 Jul 2025
ZSAN Zosano Pharma Corp Director 10 Jun 2021

Insider Transactions Reported by Steve Elms:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .